Prevention and Management of CDI and CMV in HSCT:
A Care Team Forum

1.00 CME
$0 FEE


Provider Statement

This activity is jointly provided by Postgraduate Institute for Medicine and RMEI Medical Education, LLC.
pim RMEI

Support Statement

This activity is supported by an educational grant from Merck & Co., Inc.

Target Audience

The intended audience for this activity is hematology, hematology/oncology, and infectious disease physicians, NPs, and PAs.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  1. Implement prophylactic measures for CMV in patients undergoing HSCT using evidence-based therapeutic approaches
  2. Utilize available and emerging treatment strategies for prevention of recurrent CDI in patients undergoing HSCT based on evidence-based therapeutic approaches

Roy F. Chemaly, MD, MPH, FACP, FIDSA (Chair)
Professor of Medicine 
Director, Infection Control Section
Director, Clinical Virology Research 
Department of ID/IC/EH 
UT MD Anderson Cancer Center 
Houston, TX 

Keriann Kordas, MSN, APN
Nurse Practitioner, Stem Cell Transplant Team
University of Chicago
Chicago, IL

Dayna McManus, PharmD, BCPS-AQ ID
Senior Clinical Pharmacy Specialist, Infectious Diseases
Director, PGY2 Infectious Diseases Pharmacy Residency
Yale-New Haven Hospital
New Haven, CT

Kathleen M. Mullane, DO, PharmD, FIDSA, FAST
Professor of Medicine, Section of Infectious Diseases
Director, Infectious Disease Clinical Trials
Immunocompromised Host Service
University of Chicago
Chicago, IL

Joint Accreditation Statement

ACCME Jointly accredited In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RMEI Medical Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Participate in this Activity and Obtain CME Credit

By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and PAs are entitled to receive up to 1.0 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.

Physicians, nurse practitioners, and PAs who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation. If you would like to contact Postgraduate Institute for Medicine, please email

*The expense for this gift card is solely funded by RMEI Medical Education, LLC. No supporter funding was used for the expense of this gift card.

Rules and Regulations 
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a full-service medical education company. The winner will be selected via automated random drawing on a monthly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your email address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Roy F. Chemaly, MD, MPH, FACP, FIDSA, has affiliations with Astellas, Chimerix, Merck, Oxford Immunotec (Consulting Fees); AiCuris, Chimerix, Merck, Oxford Immonotec, Shire (Contracted Research). 
  • Keriann Kordas, MSN, APN, has affiliations with Celgene (Consulting Fees); Kite (Preceptership).
  • Dayna McManus, PharmD, BCPS-AQ ID, has affiliations with Melinta Therapeutics (Consulting Fees). 
  • Kathleen M. Mullane, DO, Pharm D, FIDSA, FAST, has affiliations with Chimerix, GSK, Merck, Seynexis (Consulting Fees); Merck (Fees for Non-CME/CE Services); AiCuris, Astellas, Chimerix, Merck, Roche, Seynexis, Summit (Contracted Research).

Planners and Managers
The PIM planners and managers have nothing to disclose. RMEI Medical Education, LLC planners and managers have nothing to disclose. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

CME Questions?

If you would like to contact Postgraduate Institute for Medicine, please email